Serum calcium, phosphate, parathyroid hormone, albumin, aluminium and cholesterol achievement on replacement therapy (Chapter 9).

Serum calcium, phosphate, parathyroid hormone, albumin, aluminium and cholesterol achievement on replacement therapy (Chapter 9). Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Serum calcium, phosphate, parathyroid hormone, albumin, aluminium and cholesterol achievement on replacement therapy (Chapter 9). Abstract Text:

Edmund J Lamb,Alex Hodsman,Dirk van Schalkwyk,David Ansell,Graham Warwick,Edmund J Lamb,Alex Hodsman,Dirk van Schalkwyk,David Ansell,Graham Warwick,

In the UK, there is a continuing year-on-year trend towards improvement in serum phosphate control in dialysis patients although overall it still remains poor. The Renal Association (RA) target (<1.8 mmol/l) was achieved in 65% of patients overall, (71% of peritoneal dialysis (PD) patients, 63% of haemo dialysis (HD) patients). Seventy-six percent of UK dialysis patients achieve a corrected calcium concentration within the RA target range. As with serum phosphate, there is a trend of continuing year-on-year improvement. Nearly two-thirds (69%) of patients achieve a calcium x phosphate product within the KDOQI guidelines (<4.4 mmol(2)/l(2)): again, achievement seems to have improved year-on-year. Control was better in PD patients compared with HD patients (73% vs 67% achieving the standard). There remains large between-centre variation in the ability of renal centres to achieve the UK RA target for plasma parathyroid hormone (PTH). As seen in previous years, overall achievement was poor (median 63%, range 47-92% compliance with the standard). Most transplant patients achieve good phosphate and calcium control (99%, range 95-100%) and the percentage of patients achieving serum calcium concentrations within the target range was 84% (range 43-97%). Nearly all (99%) of transplant patients achieved calcium x phosphate product concentrations within the KDOQI target range. There would appear to be wide variation in clinical practice with respect to aluminium monitoring with a suggestion that few centres are following current UK, RA guidelines. Overall in the UK, 83% of HD, 70% of PD and 62% of transplant patients achieve a total cholesterol concentration <5 mmol/l. The percentage of patients with cholesterol <5 mmol/l has increased significantly year-on-year in all three modalities.

Serum calcium, phosphate, parathyroid hormone, albumin, aluminium and cholesterol achievement on replacement therapy (Chapter 9). Publishing Authors By Initials

EJ Lamb,A Hodsman,D van Schalkwyk,D Ansell,G Warwick,EJ Lamb,A Hodsman,D van Schalkwyk,D Ansell,G Warwick,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Serum calcium, phosphate, parathyroid hormone, albumin, aluminium and cholesterol achievement on replacement therapy (Chapter 9). Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Nephrology, dialysis, transplantation : official p

VOLUME: 22 Suppl 7

Page Numbers: vii105-vii118

Journal Abbreviation: Nephrol. Dial. Transplant.

ISSN: 0931-0509

DAY: 28

MONTH: Aug

YEAR: 2007

Serum calcium, phosphate, parathyroid hormone, albumin, aluminium and cholesterol achievement on replacement therapy (Chapter 9). Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8706402

Serum calcium, phosphate, parathyroid hormone, albumin, aluminium and cholesterol achievement on replacement therapy (Chapter 9). Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Serum calcium, phosphate, parathyroid hormone, albumin, aluminium and cholesterol achievement on replacement therapy (Chapter 9). Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Serum calcium, phosphate, parathyroid hormone, albumin, aluminium and cholesterol achievement on replacement therapy (Chapter 9).

AFFILIATION: UK Renal Registry, Southmead Hospital, Southmead Rd, Bristol, BS10 5NB, UK. Edmund.lamb@ekht.nhs.uk.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Nephrol Dial Transplant

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Serum calcium, phosphate, parathyroid hormone, albumin, aluminium and cholesterol achievement on replacement therapy Chapter 9 Related Publications

• A robust nonlinear identification algorithm using PRESS statistic and forward regression.
• Antiplatelet therapy to prevent thrombosis after hip fracture.
• Chemical constitution and anthelminthic activity of cyclic analogues of phenothiazine.
• Cull peas as a protein supplement for swine feeding.
• Fractional flow reserve of pedicled left and right internal thoracic arteries.
• Gallbladder disease in cystic fibrosis.
• High frequency chest compression effects heart rate variability.
• Influence of reproductive stage upon the fertility of gonadotrophin-treated female rabbits.
• Involving HIV-positive people in policy and service development: Recent experiences in England.
• Letter by Poullis and Warwick regarding article, "Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival".
• Management of anaemia in haemodialysis and peritoneal dialysis patients (Chapter 8).
• Mechanisms of mucous transport.
• New concepts in orthopaedic thromboprophylaxis.
• Quantitative observations on the olfactory system of the rabbit.
• Radioiodination of humic substances via azocoupling with 3-[125I] iodoaniline.
• Serum calcium, phosphate, parathyroid hormone, albumin, aluminium and cholesterol achievement on replacement therapy (Chapter 9).
• Soft X-ray Monochromators for Third-Generation Undulator Sources.
• The cat-scratch syndrome, many diseases or one disease?
• The comparison of three high-frequency chest compression devices.
• The effect of a combination antacid preparation containing aluminium hydroxide and magnesium hydroxide on rosuvastatin pharmacokinetics.
• The kinetics of effect of neuromuscular blocking drugs.
• Thoracic duct opacification for CT scanning.
• Trends in energy and macronutrient intake, body weight, level of physical activity, and energy expenditure in relation to dietary validity in female students - 1988 to 2003.
• Tubal pregnancy four months after cauterisation of the vaginal vault: One year following a vaginal hysterectomy.
• Two models of high frequency chest compression therapy: interaction of jacket pressure and mouth airflow.
• Urinary incontinence in women.
• Venous thromboembolic disease after total hip and knee arthroplasty: current perspectives in a regulated environment.
• Waveforms of High-frequency Chest Compression Systems Change With Jacket, Body.
• Why do patients known to renal services still undergo urgent dialysis initiation? A cross-sectional survey.